NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS

Venu Talla(University of Miami), John Guy(University Hospitals of Leicester NHS Trust)

Molecular Therapy

June 11, 2013

10.1038/mt.2013.104

Cited by 33

Related Papers

Gene Therapy With Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis

|Investigative Ophthalmology & Visual Science|2014|20

Targeted Krüppel-Like Factor 4 Gene Knock-Out in Retinal Ganglion Cells Improves Visual Function in Multiple Sclerosis Mouse Model

|eNeuro|2020|4